Caruso, Massimo
Emma, Rosalia
Distefano, Alfio
Rust, Sonja
Poulas, Konstantinos
Zadjali, Fahad
Giordano, Antonio
Volarevic, Vladislav
Mesiakaris, Konstantinos
Al Tobi, Mohammed
Boffo, Silvia
Arsenijevic, Aleksandar
Zuccarello, Pietro
Giallongo, Cesarina
Ferrante, Margherita
Polosa, Riccardo
Li Volti, Giovanni
Pulvirenti, Roberta
Carota, Giuseppe
Spampinato, Maria Rita
Caruso, Tancredi
Karanasios, Georgios
Albalushi, Najwa
Canciello, Angelo
Ilic, Aleksandar
,
Funding for this research was provided by:
ECLAT S.r.l.
Article History
Received: 22 July 2021
Accepted: 1 December 2021
First Online: 17 December 2021
Competing interests
: Riccardo Polosa is full tenure professor of Internal Medicine at the University of Catania (Italy). RP has received lecture fees and research funding from Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A/S, Sandoz, MSD, Boehringer Ingelheim, Novartis, Duska Therapeutics, and Forest Laboratories. RP has also received grants from European Commission initiatives (U-BIOPRED and AIRPROM) and from the Integral Rheumatology & Immunology Specialists Network (IRIS) initiative. He has also served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, CV Therapeutics, Boehringer Ingelheim, Novartis, Duska Therapeutics, ECITA (Electronic Cigarette Industry Trade Association, in the UK), Arbi Group Srl., Health Diplomats, and Sermo Inc. RP has served on the Scientific Advisory Board of Cordex Pharma, Inc., CV Therapeutics, Duska Therapeutics Inc, Pfizer, and PharmaCielo. RP is also founder of the Center for Tobacco prevention and treatment (CPCT) at the University of Catania and of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR) at the same University, which has received support from FSFW to conduct 8 independent investigator-initiated research projects on harm reduction. RP has filed a patent application concerning an app tracker for smoking behaviour developed for ECLAT Srl. RP is involved in the following pro bono activities: scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti-Smoking League), the Consumer Advocates for Smoke-free Alternatives (CASAA) and the International Network of Nicotine Consumers Organizations (INNCO); Chair of the European Technical Committee for standardization on “Requirements and test methods for emissions of electronic cigarettes” (CEN/TC 437; WG4). Giovanni Li Volti is currently elected Director of the Center of Excellence for the acceleration of HArm Reduction. Konstantinos Poulas has received service grants and research funding from a number of Vaping Companies. He is the Head of the Institute of Research and Innovations, which has received a grant from the Foundation for a Smoke Free World. All other authors declare no competing interests.